4.7 Article

The development of nonalcoholic steatohepatitis is subjected to breeder dependent variation in guinea pigs

期刊

SCIENTIFIC REPORTS
卷 11, 期 1, 页码 -

出版社

NATURE RESEARCH
DOI: 10.1038/s41598-021-82643-0

关键词

-

向作者/读者索取更多资源

This study revealed that different strains and breeders have a significant impact on the development and severity of non-alcoholic steatohepatitis (NASH). Guinea pigs from Charles River exhibited more severe NASH compared to those from Envigo, with differences in liver weight, cholesterol levels, and enzyme markers. These findings underscore the importance of considering the breeder in preclinical research for improved reproducibility and study comparisons.
Variability in disease development due to differences in strains and breeders constitutes a substantial challenge in preclinical research. However, the impact of the breeder on non-alcoholic steatohepatitis (NASH) is not yet fully elucidated. This retrospective study investigates NASH development in guinea pigs from Charles River or Envigo fed a high fat diet (20% fat, 15% sucrose, 0.35% cholesterol) for 16 or 24/25 weeks. Charles River animals displayed more severe NASH, with higher steatosis (p<0.05 at week 16), inflammation (p<0.05 at both week), fibrosis (p<0.05 at week 16) and disease activity (p<0.05 at both weeks). Accordingly, alanine and aspartate aminotransferase were increased at week 24/25 (p<0.01). Hepatic expression of inflammatory (Ccl2, Cxcl8) and fibrotic (Pdgf, Serpine1, Col1a1) genes was also increased (p<0.05). Differences were observed in healthy chow (4% fat, 0% sucrose, 0% cholesterol) fed animals: Envigo animals displayed higher relative liver weights (p<0.01 at both weeks), liver cholesterol (p<0.0001 at week 24/25) and aspartate aminotransferase (p<0.05 at week 16), but lower levels of alkaline phosphatase (p<0.0001 at week 24/25). These findings accentuates the importance of the breeder and its effect on NASH development and severity. Consequently, this may affect reproducibility, study comparison and limit the potential of developing novel therapies.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据